Ecor Pharma is the new brand from Ecor International, specializing in the design, manufacturing, and validation of turnkey solutions for the pharmaceutical sector.
It combines advanced process engineering expertise, 100% Made in Italy industrial production, and dedicated industrial microbiology laboratories to ensure high quality standards, reduce operational risks, and develop effective solutions to process challenges aligned with contamination control strategy.
The new brand builds on over 50 years of Ecor International experience in designing critical components and automated filling and packaging systems.
The Pharma division has recorded double-digit growth over the years, reaching a turnover of nearly €8 million in 2025.
EcorPharma_serbatoio
Today, it positions itself in the market as a strategic partner for the supply of pharmaceutical systems, with a particular focus on preparation and formulation suites, as well as highly customized Cleaning-in-Place and Sterilization-in-Place (CIP-SIP) systems. It offers this through dedicated pharma process consulting, drawing on deep expertise in designing and optimizing cleaning and aseptic operations.
Ecor Pharma stands out for its problem-driven approach: by first analyzing each client’s specific process challenges, it designs bespoke, fully tested, and validated system solutions.
ECOR Pharma_Fabio_Pozzebon
“We chose to give identity to an internal wealth of expertise that integrates engineering, microbiology, and research, aiming to tackle the most critical challenges of sterile production,” explains Fabio Pozzebon, Business Manager at Ecor Pharma. “We engage in direct dialogue and team up with our clients to develop effective solutions that reduce contamination risks, cleaning process inefficiencies, and sterilization issues, while simultaneously improving operational reliability, production continuity, and energy efficiency”.
Ecor Pharma will participate in CPHI Milan 2026, the premier international event for the pharmaceutical industry.
From October 6 to 8, Ecor Pharma representatives will showcase the innovative Safe Essence module to the public: a platform designed and developed to revolutionize cleaning processes in the pharmaceutical industry. Driven by dedicated AI, the system generates tailored cleaning recipes optimized for each specific pharmaceutical product.
Davide Zulpo, Key Account Manager at Ecor Pharma, concludes: “We listen to the pharmaceutical industry’s need to minimize risks during the cleaning process and optimize water and energy consumption. We look to the future with a clear growth plan, confident that the future of this sector belongs to those who can combine scientific rigor, technological innovation, and an industrial vision”.
